We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+17.22%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
AUM
$270M
AUM Growth
+$52.1M
Cap. Flow
+$22M
Cap. Flow %
8.14%
Top 10 Hldgs %
40.76%
Holding
941
New
464
Increased
200
Reduced
32
Closed
8

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.34M
2
XOM icon
ExxonMobil
XOM
+$1.31M
3
CVX icon
Chevron
CVX
+$1.25M
4
LLY icon
Eli Lilly
LLY
+$685K
5
JPM icon
JPMorgan Chase
JPM
+$684K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.18M
2
NVDA icon
NVIDIA
NVDA
+$618K
3
AVGO icon
Broadcom
AVGO
+$138K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$113K
5
AAPL icon
Apple
AAPL
+$105K

Sector Composition

Rank Sector Weight
1 Technology 44.15%
2 Healthcare 9.98%
3 Consumer Staples 7.57%
4 Financials 6.32%
5 Industrials 6.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVO
326
Novo Nordisk
NVO
$216B
$29.4K 0.01%
+229
New +$27.3K
LKQ icon
327
LKQ Corp
LKQ
$6.58B
$29.2K 0.01%
+547
New +$27.1K
HXL icon
328
Hexcel
HXL
$8.32B
$28.8K 0.01%
395
+115
+41% +$8.27K
ESS icon
329
Essex Property Trust
ESS
$18.9B
$28.7K 0.01%
+116
New +$27.6K
AVT icon
330
Avnet
AVT
$7.33B
$28.5K 0.01%
+574
New +$26.9K
ARE icon
331
Alexandria Real Estate Equities
ARE
$8.88B
$28.4K 0.01%
+218
New +$26.9K
CVS icon
332
CVS Health
CVS
$137B
$28.3K 0.01%
355
+150
+73% +$11.5K
FNDF icon
333
Schwab Fundamental International Large Company Index ETF
FNDF
$24.3B
$28.3K 0.01%
795
+200
+34% +$6.79K
EMN icon
334
Eastman Chemical
EMN
$7.8B
$28K 0.01%
+277
New +$24.4K
HUM icon
335
Humana
HUM
$46.7B
$27.8K 0.01%
+80
New +$30.3K
ICSH icon
336
iShares Ultra Short Duration Bond Active ETF
ICSH
$7.97B
$27.8K 0.01%
550
SJNK icon
337
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.89B
$27.4K 0.01%
1,088
+938
+625% +$23.6K
ITOT icon
338
iShares Core S&P Total US Stock Market ETF
ITOT
$93.2B
$27.3K 0.01%
237
+8
+3% +$877
ABUS icon
339
Arbutus Biopharma
ABUS
$865M
$27.1K 0.01%
10,500
IDU icon
340
iShares US Utilities ETF
IDU
$1.41B
$27K 0.01%
320
AKAM icon
341
Akamai
AKAM
$16.8B
$27K 0.01%
+248
New +$28.6K
AMD icon
342
Advanced Micro Devices
AMD
$851B
$26.9K 0.01%
+149
New +$26K
ALLE icon
343
Allegion
ALLE
$13B
$26.8K 0.01%
198
+97
+96% +$12.4K
CORP icon
344
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.57B
$26.4K 0.01%
275
ALK icon
345
Alaska Air
ALK
$5.15B
$26K 0.01%
605
MPC icon
346
Marathon Petroleum
MPC
$90.3B
$26K 0.01%
+129
New +$22.1K
URI icon
347
United Rentals
URI
$71.1B
$26K 0.01%
+36
New +$23.1K
NOW icon
348
ServiceNow
NOW
$102B
$25.9K 0.01%
+170
New +$25.8K
BDX icon
349
Becton Dickinson
BDX
$43.1B
$25.9K 0.01%
104
+103
+10,300% +$24.7K
ICF icon
350
iShares Select U.S. REIT ETF
ICF
$2.12B
$25.8K 0.01%
447
+212
+90% +$12.1K

Similar funds

Front Row Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Front Row Advisors held 941 positions worth $270M, up 24% from $218M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Front Row Advisors deployed $22M of net new capital in Q1 2024, opening 464 new positions and adding to 200 existing holdings. Its largest new stake was Vanguard Information Technology ETF: 8,008 shares worth $525K.

By sector, the portfolio is most concentrated in Technology at 44% of assets, down from 46% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Pfizer, an estimated $1.18M trimmed.

  • Front Row Advisors's largest Q1 2024 buy was Vanguard Information Technology ETF: 8,008 shares worth $525K.
  • Front Row Advisors added most to Berkshire Hathaway Class B in Q1 2024, an estimated $1.34M increase.
  • Front Row Advisors's biggest Q1 2024 reduction was Pfizer, cutting an estimated $1.18M.
  • Front Row Advisors fully exited Atlantica Sustainable Infrastructure plc Ordinary Shares in Q1 2024, selling an estimated $16.2K.
  • Front Row Advisors's ten largest holdings make up 41% of its $270M portfolio in Q1 2024.
  • Front Row Advisors opened 464 new positions and closed 8 in Q1 2024.
  • Front Row Advisors's portfolio value rose 24% quarter-over-quarter to $270M.

Based on Front Row Advisors's 13F filing for Q1 2024, filed 14 May 2024.